Position in LLY
as of Jun 30, 2026
· filed Jul 17, 2026
Position Value
$24,168,514
+$5,886,249 QoQ
Shares Held
20,150
+1.4% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#818
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Ballentine Partners, LLC holds $83,408,432 across 14 Drug Manufacturers - General names. LLY ranks #1 (29.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
20,150 | $24,168,514 | |
| 2 | JNJ |
Johnson & Johnson
|
66,025 | $16,768,367 | |
| 3 | ABBV |
AbbVie Inc.
|
42,284 | $10,640,343 | |
| 4 | MRK |
Merck & Co., Inc.
|
52,463 | $6,741,493 | |
| 5 | NVS |
Novartis AG
|
29,508 | $4,624,493 | |
| 6 | AZN |
Astrazeneca PLC
|
20,071 | $3,805,862 | |
| 7 | AMGN |
Amgen Inc
|
10,242 | $3,708,831 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
24,093 | $3,043,907 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $24,168,514 | 20,150 | Shares | Other | 2026-07-17 | |
| 2026-03-31 | $18,282,265 | 19,877 | Shares | Other | 2026-05-14 | |
| 2025-12-31 | $20,845,567 | 19,397 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $14,432,908 | 18,916 | Shares | Other | 2025-11-03 | |
| 2025-06-30 | $13,707,254 | 17,584 | Shares | Other | 2025-07-15 | |
| 2025-03-31 | $14,827,560 | 17,953 | Shares | Other | 2025-05-01 | |
| 2024-12-31 | $13,324,720 | 17,260 | Shares | Other | 2025-01-16 | |
| 2024-09-30 | $15,044,145 | 16,981 | Shares | Sole | 2024-10-23 | |
| 2024-06-30 | $14,830,123 | 16,380 | Shares | Sole | 2024-08-06 | |
| 2024-03-31 | $11,852,219 | 15,235 | Shares | Sole | 2024-04-11 | |
| 2023-12-31 | $8,040,214 | 13,793 | Shares | Sole | 2024-01-23 | |
| 2023-09-30 | $6,834,441 | 12,724 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $5,792,839 | 12,352 | Shares | Sole | 2023-07-26 | |
| 2023-03-31 | $4,024,881 | 11,720 | Shares | Other | 2023-04-27 | |
| 2022-12-31 | $2,569,293 | 7,023 | Shares | Sole | 2023-01-27 | |
| 2022-09-30 | $2,111,151 | 6,529 | Shares | Other | 2022-10-26 | |
| 2022-06-30 | $1,659,732 | 5,119 | Shares | Other | 2022-08-09 | |
| 2022-03-31 | $1,306,991 | 4,564 | Shares | Other | 2022-05-05 | |
| 2021-12-31 | $1,136,368 | 4,114 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $871,981 | 3,774 | Shares | Sole | 2021-10-27 | |
| 2021-06-30 | $855,190 | 3,726 | Shares | Other | 2021-08-12 | |
| 2021-03-31 | $703,562 | 3,766 | Shares | Other | 2021-05-11 | |
| 2020-12-31 | $627,409 | 3,716 | Shares | Other | 2021-01-25 | |
| 2020-09-30 | $780,952 | 5,276 | Shares | Other | 2020-10-22 | |
| 2020-06-30 | $821,720 | 5,005 | Shares | Other | 2020-07-31 | |
| 2020-03-31 | $682,917 | 4,923 | Shares | Other | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||